NATICK, Mass., Aug. 2 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX - News) today provided an update on its plans to strengthen operating and financial performance as part of its overall strategy of restoring growth, increasing sustainable short- and long-term shareholder value, and continuing to build a broad, diversified medical device company.
